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Bacillary dysentery remains one of the most important diarrhoeal diseases affecting humans in the 21
st 
century 
particularly in resource-poor nations.
1
 The etiological agents of this disease, Shigella bacteria, derive from 
diverse origins of Escherichia coli.
2,3
 Shigella sonnei is the causative agent for the current bacillary dysentery 
pandemic in many of the newly industrialised countries across all continents and has replaced Shigella flexneri, 
once the most prevalent species globally.
1
 Contemporary epidemic S. sonnei strains mostly belong to the 
lineage III and exhibit multiple drug resistance due to the spread of transposons and independent point 
mutations in the gyrase gene.
4
 In addition to that, developing an effective vaccine against Shigella remains a 
challenge.
5
 Hence, it has become urgent to seek alternative approaches to treat Shigella infection. Here, we 
show that geraniol, a natural substance present in the essential oils of plants such as rose and lemongrass 
6
 can 
reduce S. sonnei proliferation inside host cells and protect Galleria mellonella larvae from killing by S. sonnei 
infection. We present evidence that geraniol competitively inhibits the catalytic activity of the master virulence 
regulator, DsbA, a periplasmic disulphide bond oxidoreductase required for Shigella survival in the host cell 
cytosol.
7
   
It has been previously reported that a natural flavonoid called propolin D could moderately reduce the 
production of inflammatory cytokines IL-1 and IL-18 from infected macrophage-like U937 cells and inhibit the 
intracellular proliferation of S. sonnei in this cell line as well as in epithelial HEp-2 cells.
8
 Following on from this 
study, here, we treated HEK 293 cells with propolin D for one hour followed by staining with acridine orange. 
The latter is a dye which emits a red fluorescence upon non-covalent binding to negatively-charged and 
aromatic molecules 
9
 such as a flavonoid like propolin D would be once inside HEK 293 cells (pH 7.3) owing to 
its 3',4'-disubstituted pattern.
10
 The heavily stained HEK 293 cells were evidence of a strong accumulation of 
propolin D intracellularly.  In contrast, eriodictyol, a compound that shares identical flavonoid rings but lacks 
the prenylated (terpene-derived) side chain, showed very little intracellular accumulation (Fig. 1A). Not 
surprisingly, only supplementation of 42 µM propolin D, but not of 42 µM eriodictyol, in the culture medium 
was able to inhibit S. sonnei growth inside HEK 293 cells (data not shown). These observations strongly 
suggested that the terpenic side chain was responsible for the accumulation of propolin D, and its activity on 
Shigella, inside host cells. As many terpenes are known to possess antimicrobial activity,
11
 this led us to 
hypothesise that the terpenic side chain could be the key moiety responsible for the inhibition of S. sonnei 
intracellular growth.  
To test this hypothesis, we examined twelve terpenes for their potential in inhibiting intracellular S. 
sonnei growth using a gentamicin-killing assay.
8
 The monoterpene geraniol (Fig. 1B) was found to be the most 
potent among the tested compounds, with as little as 42 µM significantly inhibiting intracellular bacterial 
growth (P < 0.01) (Fig. 1C). We further exploited a Galleria mellonella larvae model developed as a simple in 
vivo model to assess Shigella virulence.
12
 As shown in Fig. 1D, the injection of 10
5
 of S. sonnei bacteria killed all 
10 larvae in one day while the use of geraniol at doses of 350, 175, 87.5 and  62.5 mg/kg significantly improved 
larval survival compared to Shigella-infected untreated larvae (P < 0.05). We observed that the use of 62.5 
mg/kg of geraniol could significantly protect 40 % of larvae for 5 days (P = 0.0118) and that all larvae were 
completely protected for 5 days when treated with 350 mg/kg of geraniol (P < 0.0001). We also used the 
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Galleria mellonella larvae model to examine the cytotoxicity of geraniol and found that all larvae survived for 5 
days when up to 3.5 g/kg of geraniol was administered per larvae (Fig. 1E). However, compared to the mock-
infected control, all larvae were killed in one day when 35 g/kg of geraniol was given per larvae (P < 0.0001), 
which had the same killing capacity as a S. sonnei infection at 10
5
 bacteria per larvae. Thus, the larvae 
tolerance level was at least 10-fold higher than the therapeutic level required to control S. sonnei infection. 
Propolin D has previously been shown to possess potent activity against Staphylococcus aureus but no 
direct activity against a Gram-negative bacterium such as Pseudomonas aeruginosa.
13
 We found that this was 
also true for geraniol, which had little direct inhibition on S. sonnei growth when tested using a microdilution 
assay
14
 in a rich broth such as Luria-Bertani and in a minimal M9 broth (MIC > 500 mg/L). These facts strongly 
suggested that propolin D, as well as geraniol, could either enhance a host defence mechanism responsible for 
controlling intracellular bacteria or target a bacterial factor only active inside the host cell cytosol where 
Shigella thrives.
15
  
Previous studies revealed that the Shigella periplasmic disulphide bond oxidoreductase, DsbA, is vital in 
supporting the survival of S. flexneri in the host cell cytosol.
7
 The latter is a highly reducing environment with 
high concentrations of reduced glutathione (GSH) because the cytosolic thioredoxin-1 and reduced glutathione 
(GSH)/oxidised glutathione (GSSG) redox couples are not in equilibrium.
16
 We hypothesised, here, that Shigella 
uses DsbA to convert excessive GSH to GSSG, as a way to overcome the stress caused by the highly reducing 
cytosolic environment and thus survive and grow inside cells.
7
 We investigated if geraniol could inhibit the 
enzymatic activity of Shigella DsbA in vitro and inside host cells.  
Although DsbA is fundamentally a disulphide bond catalyst,
17
 it does exhibit reduction activity in a 
scrambled ribonuclease assay similarly to the mammalian protein disulphide isomerase (PDI).
18
 We first 
performed an in vitro assay using fluorescent di-eosin-glutathione disulfide (Di-E-GSSG) according to a 
previously published methodology.
19
 Di-E-GSSG is not brightly fluorescent in its disulfide form due to self-
quenching, but reduced eosin-glutathione (E-GSH) formed upon reduction of the disulphide bond by PDI, emits 
strong fluorescence at 545 nm when excited at 525 nm.
19
 In order to use DsbA in this assay, we purified the 
wild type Shigella DsbA protein as well as a mutant DsbA33G protein that had a substitution of cysteine 33 for 
glycine 33 at the active site.
20
 As shown in Fig. 2A, the wild type DsbA protein was able to effectively convert 
Di-E-GSSG to a more fluorescent E-GSH with an estimated Vmax of 14.97 ± 5.39 RFU/s whereas the mutant 
protein DsbA33G had a Vmax of 10.14 ± 3.44 RFU/s. Importantly, in the presence of 42 µM of geraniol, the 
wild type DsbA and DsbA33G both had significantly reduced Vmax values (13.89 ± 5.05 RFU/s and 9.03 ± 3.44 
RFU/s, respectively). These data demonstrated that glutathione is indeed a substrate for Shigella DsbA, and 
that geraniol may inhibit the reductive activity of DsbA on Di-E-GSSG. To further characterise the type of 
inhibition involved, we produced Lineweaver-Burk plots in the presence and absence of geraniol for DsbA and 
DsbA33G (Fig. 2B and Fig 2C, respectively). It was clear that geraniol competitively inhibited the DsbA-
catalysed reduction of Di-E-GSSG as the Y-intercept (1/V) was not changed but the line was shifted to the right 
on the X-axis (1/S) in the presence of geraniol. The Km values for DsbA were estimated as 200.3 and 331.8 nM, 
in the absence and presence of 42 µM geraniol, respectively (Fig. 2B). Interestingly, Km values for DsbA33G 
were estimated as 537.6 and 331.8 nM in the absence and presence and of 42 µM geraniol, respectively (Fig. 
2C). This is consistent with the fact that, at low concentrations of Di-E-GSSG, an addition of geraniol moved the 
curve to the left on the X-axis (1/S) and accelerated the reaction of DsbA33G (arrow in Fig. 2A). 
The above data have demonstrated that glutathione is a substrate for Shigella DsbA. However, a 
fundamental question remains unanswered: does Shigella DsbA catalyse reduced GSH to oxidised GSSG, which 
is hypothesised to be vital for Shigella to survive and proliferate in the host cell cytosol 
7
.  As no in vitro assay 
has been described, we set up an in vivo assay using fluorescent E-GSH. Weakly fluorescent Di-E-GSSG was 
completely reduced with 10 mM DTT to highly fluorescent E-GSH. We then added 75 nM of E-GSH to Luria-
Bertani broth that was used to culture a wild type as well as a mutant Shigella strain in which the dsbA gene 
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was deleted (ȴdsbA). As the wild type strain grew, the fluorescence of the culture gradually decreased, from 
5,000 to 2,000 RFU, over time (Fig. 3A). In contrast, the culture of the ȴDsbA strain showed no reduction in 
fluorescence although the mutant strain grew well under such mildly reducing conditions (Fig. 3B). As 
anticipated, the complemented strain ȴDsbA/pDsbA showed the same ability in reducing the culture 
fluorescence, from 5,000 to 2,000 RFU, over time, presumably due to the over expression of DsbA from the 
plasmid (Fig. 3C). Importantly, geraniol (42 µM) inhibited the wild type as well as the complemented strains in 
conversion of E-GSH to Di-E-GSSG; the reduction of fluorescence did not go below 4000 RFU (Fig. 3A, 3B). To 
our knowledge, this is the first time that Shigella DsbA has been shown to catalyse GSH to GSSG, which 
strongly support the hypothesis that catalysis of GSH to GSSG in the host cell cytosol is imperative for Shigella 
to survive, proliferate and establish infection.
7
 
Antimicrobial resistance has emerged as a major challenge to modern medicine and public health and 
fast-evolving multi-resistant clones are the cause of the current S. sonnei pandemic.
4
 The chilling fact is that 
antimicrobial resistance will occur to any new antibiotic sooner or later. The major advantage of targeting 
virulence in intracellular pathogens, is that there is a very remote possibility for resistance mechanisms to 
develop.
21
  
DsbA is present in all Gram-negative bacteria and some Gram-positive bacteria, including in many 
pathogens of human and animals. DsbA is considered as a master virulence regulator as it catalyses the 
formation of disulphide bond formation in exported proteins, of which many are virulence factors.
22
 Targeting 
Dsb proteins for anti-virulence therapy is not new but previous studies focusing on disrupting DsbA-DsbB 
interaction have yielded little progress; DsbB is required for recycling the non-functional reduced DsbA to its 
functional oxidised form.
22
 Our study presents for the first time a way of controlling S. sonnei infection via 
inhibition of DsbA inside host cells. Our observations may also be relevant to control other intracellular 
pathogens such as Francisella tularensis that thrive in the host cytosol and require DsbA.
23
 It is also of interest 
to note that previous studies have showed that geraniol can modulate the host immune system for the 
production of anti-inflammatory cytokines such as IL-10,
24
 which could be of particular interest in bacillary 
dysentery where there is hyper-inflammation. We have also gathered some additional (unpublished) evidence 
that geraniol is able to inhibit the growth of adhesive and invasive Escherichia coli inside macrophages. Such 
ďĂĐƚĞƌŝĂŚĂǀĞďĞĞŶŝĚĞŶƚŝĨŝĞĚĂƐĂŬĞǇĂĞƚŝŽůŽŐŝĐĂůĨĂĐƚŽƌƚŽƌŽŚŶ ?ƐĚŝƐĞĂƐĞ ?ĂŶŽƚŚĞƌŚǇƉĞƌ-inflammatory 
condition affecting the bowel.
25
 Additionally, geraniol has been shown to work in synergy with antibiotics.
26
 
Taken altogether, these observations indicate that geraniol holds a great therapeutic potential that should be 
further exploited. 
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Figure legends 
Figure 1. Cellular location of propolin D and functional analysis of geraniol. (A) Propolin D, 
but not eriodictyol, accumulates inside HEK 293 cells. Cells were treated with propolin D (42 
µM), eriodictyol (42 µM) or DMSO (solvent used to solubilise the compounds) for 1 h. 
Following washes with PBS (3x for 5 min), cells were fixed with 3.7% paraformaldehyde and 
stained with 10 mM acridine orange for 15 min. Cells were further stained with DAPI (for 
ŶƵĐůĞŝ ?ĂŶĚůĞǆĂ&ůƵŽƌ ? ? ? ?ƉŚĂůůŽŝĚŝŶ ?ĨŽƌĂĐƚŝŶ ?ĂĐĐŽƌĚŝŶŐƚŽƚŚĞŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ
instructions (Sigma Aldrich, UK).  Images were taken using a confocal microscope (Leica 
Microsystems). Propolin D was detected under excitation at 502 nm and emission at 526 
nm; cell nuclei were detected under excitation at 350 nm and emission at 470 nm and actin 
was detected under excitation at 488 nm and emission at 509 nm. (B) Chemical structure of 
geraniol. (C) Geraniol significantly reduces S. sonnei proliferation inside HeLa cells. The 
effect of geraniol and other natural terpenes on S. sonnei intracellular growth was 
determined by a gentamicin-killing assay.
8 
Cells were infected with S. sonnei for 2 h in the 
presence of terpenes Ăƚ ? ?ʅDĐŽŶĐĞŶƚƌĂƚŝŽŶs. The cells were lysed 2 h post-infection with 
0.1 Triton X-100 and lysates were plated out on Luria-Bertani agar plates for enumeration of 
colony forming units (CFU). Experiments were carried out in triplicates and repeated twice. 
Data shown are pooled means + SD. Differences between untreated and treated groups 
were assessed using the ^ƚƵĚĞŶƚ ?Ɛt-test (* P < 0.05; ** P < 0.01). (D) Geraniol protects 
Galleria mellonella (wax moth) larvae from killing by S. sonnei. Experiments were carried out 
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as described using 2-3 days old larvae; 10 larvae per group.
12  
For infection, 10 µL of a 
bacterial suspension containing 10
5
 of live S. sonnei was injected to the right front leg of 
each larva. Mock infection was done by injection of PBS. For geraniol protection, geraniol 
(10 µL) was injected at the indicated doses to the left front leg of each larva. All larvae were 
observed for 5 days. Larvae death is indicative by melanisation and loss of mobility. 
Experiments were repeated three times (n=3) and pooled data were used to generate the 
graphs. Differences between Shigella-infected untreated and treated groups were assessed 
using the Gehan-Breslow-Wilcoxon test with a significance value set at P < 0.05. (E) 
Cytotoxicity of geraniol to Galleria mellonella larvae. Each group contained 10 larvae as in D, 
geraniol (10 µL) was injected at the indicated doses to the front leg of each larva. A mock 
treatment was done using PBS. All observations were done as in D. Differences between 
treated groups and the mock-infected control were assessed using the Gehan-Breslow-
Wilcoxon test with a significance value set at P < 0.05. 
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Figure 2. Reduction of Di-E-GSSG by DsbA proteins in vitro. (A) Reducing activity of wild type 
DsbA and DsbA33G in the presence and absence of geraniol. DsbA or DsbA33G (40 nM) was 
incubated with various concentrations of Di-E-GSSG (50 nM - 5 µM) in a DsbA assay buffer at 
room temperature according to a previously published method.
19 
Fluorescence was 
measured with excitation at 525 nm and emission at 545 nm using a Spectramax microplate 
reader M5 (Molecular device). Conversion of Di-E-GSSG was expressed as relative 
fluorescence unit per second (RFU/s).  Theoretical hyperbolic curves allowed the estimation 
of the Vmax for wild type DsbA and for DsbA33G (14.97 ± 5.39 and 10.14 ± 3.44 RFU/s, 
respectively). In the presence of 42 µM of geraniol, the Vmax values were significantly 
reduced to 13.89 ± 5.05 and 9.03 ± 3.44 RFU/s, respectively (P = 0.0052 and 0.0069, 
respectively). Error bars were removed for clarity. Km values were estimated using the 
Lineweaver-Burk plot for DsbA (B) and DsbA33G (C). Km was estimated as 200.3 and 331.8 
nM for DsbA without and with 42 µM geraniol, respectively. Km was estimated as 537.6 and 
331.8 nM for DsbA33G without and with geraniol, respectively. All experiments were 
repeated three times (n=3) in triplicates each time.  Data shown are pooled means + SD. 
Statistical significance was calculated using the Bonferroni correction t test with a 
significance value set at P < 0.01.  
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Figure 3. Analysis of DsbA enzymatic activity in vivo. Wild type (A), ȴĚƐď(B) and 
complemented (ȴĚƐď /pDsbA) (C) Shigella sonnei strains were grown in LB-broth 
supplemented with E-GSH (75 nM) in the absence and presence of geraniol (42 µM). 
Bacterial growth was measured by optical density (OD600nm; right axes) over time. The 
formation of Di-E-GSSG was measured by relative fluorescence units (RFUs; left axes) with 
excitation at 525 nm and emission at 545 nm using a Spectramax microplate reader M5 
(Molecular device) over time. The experiments were repeated twice (n=2) in triplicates each 
time and pooled data were used to generate the graphs. Error bars were removed for 
clarity. 
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